79° Good Evening
79° Good Evening
BusinessPress Releases

M3 Global Research Matches Donated Honoraria to Aid with Philippine Typhoon Recovery

Research Panel Physicians offered opportunity to donate honorarium to Red Cross, with all donations matched up to $10,000 by M3 Global Research, a part of M3 Group.

Washington, DC (PRWEB) December 13, 2013

M3 Global Research, (, a market leader with the world’s largest verified healthcare professional panel, announced their global initiative to help Red Cross Typhoon Haiyan relief efforts in the Philippines.

“It was the most powerful typhoon to hit the Philippines in 30 Years,” commented Jessica McCann, VP of Global Operations. “As a global company, M3 felt the need to get involved to help the Philippine people to continue to recover from the devastation. That’s why we offered our compassionate, expert physician research panel base an opportunity to donate their honorarium, of which M3 will match up to $10,000 this year.”

M3 conducts global quantitative and qualitative medical market research with panels that reach over 2.5 million physicians worldwide digitally and has a healthcare professional reach that exceeds 4 million when including nurses, dentists, physician assistants, lab managers, payers, and pharmacists.

About M3 Group
The M3 Group operates in the US, Asia, and Europe with over 2.5 million physician members globally via its physician websites such as,,, and M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413) with subsidiaries in major markets including USA, UK, Japan, S. Korea, and China. M3 Group provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Tokyo, Washington D.C., Fort Washington, PA, Oxford, London, and Seoul.

M3 Group Sites

For the original version on PRWeb visit:


We're revamping our Comments section. Learn more and share your input.

More news